Accentia Biopharmaceuticals Inc.

Accentia Biopharmaceuticals, Inc., a biotechnology company, primarily discovers, develops, and commercializes immunotherapies to treat autoimmune related diseases and cancer in the United States. It operates in two segments: Biopharmaceutical Products and Services, and Specialty Pharmaceuticals. The Biopharmaceutical Products and Services segment develops late-stage biopharmaceutical products. The Specialty Pharmaceuticals segment markets and sells pharmaceutical products that are developed primarily by third-party development partners.

Acquired Companies: TEAMM Pharmaceuticals Inc.
Currently not active.
DEVELOPMENT STAGES
Development Stages


MOLECULE TYPES
Molecule Types


PRODUCT TYPES
Product Type


DRUG SUBSTANCE OR API
API Equipment and Process Capabilities


API Related Services


Warning

Close